GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FDPS, HSD11B1, HSD17B1, MET, PPARA, PPARG, TRPV1 |
10.4934 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, KDR, MAOB, MET, PPARA, PPARG, SRC, TRPV1, XDH |
10.4934 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MMP2, NR3C1, PPARA, PPARG, SRC, TRPV1 |
8.66333 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FABP3, HSP90AB1, IGF1R, MAOB, MMP2, MMP9, NR3C1, PPARA, PPARG, SRC, TRPV1 |
8.25886 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
7.78924 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
7.73842 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
7.73842 |
[BP] GO:0014070 |
response to organic cyclic compound
|
BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FLT3, HSP90AB1, MAOB, NR3C1, PPARG, SRC, TRPV1 |
7.73842 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FDPS, PDE5A, PIM1, PPARA, PPARG, XDH |
7.72884 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MMP2, MMP9, NR3C1, PPARA, PPARG, SRC, TRPV1 |
7.60037 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MAOB, MMP9, SRC |
7.33476 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.32627 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, FDPS, HSD11B1, HSD17B1 |
6.97393 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FDPS, MET, PPARA, PPARG |
6.95721 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.95431 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, FABP3, FLT3, IGF1R, MAOB, MMP2, NR3C1, PPARA, PPARG, SRC, TRPV1 |
6.85605 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSP90AB1, KDR, MAOB, NR3C1, PPARG, SRC, TRPV1 |
6.84187 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.82376 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
6.65368 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.65368 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.62159 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, FLT3, MAOB, NR3C1, PPARA, PPARG, SRC, TRPV1 |
6.59826 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARG, SRC, TRPV1, XDH |
6.45294 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.41627 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG |
6.35273 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.31602 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.26592 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, XDH |
6.24397 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX12, ALOX15, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, FDPS, MAOB |
5.99361 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, PPARG, TRPV1 |
5.96722 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HSP90AB1, KDR, MET, MMP9, PDE5A, SRC, XDH |
5.93789 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, ALOX15, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HCAR2, HSP90AB1, KDR, MET, MMP9, PDE5A, SRC, XDH |
5.91515 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 |
5.91515 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1 |
5.87644 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, MAOB, PPARG, XDH |
5.86355 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARG, SRC, TRPV1, XDH |
5.85116 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.85116 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, ALOX12, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, MET, PPARG, SRC, TRPV1 |
5.77802 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AXL, BCL2, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, NR3C1, PPARG, SRC, TRPV1 |
5.7198 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1 |
5.65402 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, FABP3, FLT3, MAOB, NR3C1, PPARG, SRC |
5.33929 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CHRM1, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PDE5A, PIM1, PPARG, SRC, XDH |
5.32065 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.28016 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.27312 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ALOX12, ALOX15, AXL, BCL2, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, HCAR2, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, PPARA, PPARG, SRC, TRPV1 |
5.24672 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, HSP90AA1, KDR, MAOB, SRC |
5.21815 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
5.0615 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, PPARG, TRPV1 |
4.88545 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALOX15, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FLT3, HSD11B1, HSP90AB1, KDR, MAOB, MMP9, PIM1, PPARA, PPARG, SRC |
4.86255 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
CYP1A1, CYP1B1, DRD1, ESR1, FLT3, HSP90AB1, NR3C1, PPARG, SRC, TRPV1 |
4.76371 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.57268 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG |
4.51838 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, HSP90AB1, KDR, NR3C1, SRC, TRPV1 |
4.5062 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.50361 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PDE5A, PPARG, SRC, XDH |
4.46977 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD1, DRD2, KDR, SRC, TRPV1 |
4.41197 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, FLT3, HSD11B1, HSP90AB1, KDR, PPARA, PPARG, SRC |
4.38391 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CHRM1, CSNK2A1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1 |
4.38011 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, HSP90AB1, IGF1R, KDR, MET, MMP9, PDE5A, PPARG, SRC, XDH |
4.38011 |
[BP] GO:0040012 |
regulation of locomotion
|
ALOX12, BCL2, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, SRC |
4.35562 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HCAR2, HSD11B1, HSD17B1 |
4.31716 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, ALOX12, ALOX15, ALOX5, AXL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, F3, FABP4, IGF1R, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, SRC, TRPV1 |
4.30359 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, BCL2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
4.27032 |
[BP] GO:0030334 |
regulation of cell migration
|
ALOX12, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, SRC |
4.24427 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, BCL2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
4.24138 |
[BP] GO:0051972 |
regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
4.16166 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, MET, PIM1, SRC |
4.16166 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MAOB, MMP9 |
4.14904 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, MET, PPARG, TRPV1 |
4.09775 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA9, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, FABP4, FLT3, HSD11B1, HSP90AB1, KDR, MAOB, MET, MMP2, MMP9, PIM1, PPARA, PPARG, SRC |
4.09565 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 |
4.0723 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
4.0723 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, AXL, BCL2, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1 |
4.06676 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HSD11B1, HSD17B1 |
4.02297 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
4.01327 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, HSP90AA1, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH |
4.00237 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
3.99474 |
[BP] GO:2000145 |
regulation of cell motility
|
ALOX12, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, SRC |
3.99474 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.96438 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.96438 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ALOX15, AURKB, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PPARA, PPARG, SRC, TRPV1, XDH |
3.90332 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.90193 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, HSP90AA1, HSP90AB1, MAOB, TRPV1 |
3.88306 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, NR3C1, PIM1, PPARA, PPARG, SRC |
3.86839 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, SRC, TRPV1 |
3.85955 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, MAOB, NR3C1, PPARG, SRC |
3.84108 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.84108 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.84108 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1 |
3.79919 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.79698 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CHRM5, CYP1A1, FABP3, FDPS, FLT3, HCAR2, PPARA, PPARG, SRC |
3.79483 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, AXL, BCL2, CA2, CHRM3, CYP1B1, DRD2, F3, HCAR2, KDR, MET, MMP9, PDE5A, PIM1, PPARG, SRC, TRPV1 |
3.79327 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, HSP90AB1 |
3.79116 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, DRD1, DRD2, HCAR2, KDR, SRC, TRPV1 |
3.79116 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.75488 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.75421 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
AKR1B1, ALOX12, DRD1, DRD2, MET, TRPV1 |
3.72245 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.7142 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ALOX12, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, PPARG, SRC |
3.69623 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ALOX15, AURKB, BCL2, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PPARA, PPARG, SRC, TRPV1, XDH |
3.69179 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.69179 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ALOX15, AURKB, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PPARA, PPARG, SRC, TRPV1, XDH |
3.67889 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AXL, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, NR3C1, PPARG, SRC, TRPV1 |
3.67889 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TRPV1 |
3.64012 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP2, MMP9, PDE5A, PPARA, PPARG, SRC, XDH |
3.63539 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.63412 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, ESR1, PPARA, PPARG, SRC |
3.63412 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HSD11B1, HSD17B1 |
3.59014 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, NR3C1, PPARA, PPARG, SRC |
3.52486 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, SRC |
3.52486 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, IGF1R, KDR, MET, MMP9, PDE5A, SRC, XDH |
3.52375 |
[BP] GO:0065007 |
biological regulation
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
3.4811 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, MAOB |
3.45564 |
[BP] GO:0007193 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2 |
3.41901 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.41619 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ALOX15, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, HCAR2, HSP90AB1, MAOB, MMP9, PPARA, PPARG, SRC, TRPV1 |
3.40873 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, HCAR2, HSP90AB1, PPARG, SRC, TRPV1 |
3.39943 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, MAOB |
3.37413 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, FABP3, FLT3, HSP90AB1, IGF1R, MMP2, PPARA, PPARG, SRC, TRPV1 |
3.354 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, KDR, MET, PDE5A, SRC, XDH |
3.35188 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALOX15, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MMP2, MMP9, NR3C1, PPARA, PPARG, SRC, TRPV1 |
3.30659 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HSP90AB1, KDR, MET, MMP9, PDE5A, SRC, XDH |
3.28055 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, HCAR2, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
3.26464 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.22171 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HSP90AB1, IGF1R, KDR, MMP9, PIM1, SRC |
3.19994 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.19994 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
3.19548 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG |
3.18664 |
[BP] GO:0007188 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2 |
3.13701 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, FDPS, FLT3, HSP90AA1, IGF1R, KDR, MET, PDE5A, PIM1, SRC, XDH |
3.12894 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, HSP90AB1, MET, MMP9, PPARA, PPARG, SRC |
3.12198 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.12198 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, ALOX15, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FABP4, FLT3, HSP90AA1, HSP90AB1, KDR, MET, MMP2, MMP9, PDE5A, SRC, XDH |
3.11933 |
[BP] GO:0046903 |
None
|
ALOX5, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, HSP90AA1, HSP90AB1, MMP9, TRPV1, XDH |
3.08147 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ALOX12, AXL, BCL2, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, ESR1, F3, HCAR2, HSP90AB1, KDR, MET, MMP9, PDE5A, PIM1, PPARG, SRC, TRPV1, XDH |
3.08053 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
3.06795 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, MAOB |
3.06795 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, FDPS |
3.06465 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.04089 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.03086 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
3.03086 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
3.03086 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
3.03086 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, NR3C1, PPARA, PPARG, SRC |
3.01202 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, HSP90AA1, HSP90AB1, TRPV1, XDH |
2.98469 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.94258 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.91684 |
[BP] GO:0006939 |
None
|
CHRM3, DRD1, DRD2, TRPV1 |
2.90909 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, AURKB, AXL, BCL2, CSNK2A1, DRD1, DRD2, FDPS, FLT3, HSP90AA1, IGF1R, KDR, MET, PDE5A, PIM1, SRC, XDH |
2.90436 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.88057 |
[BP] GO:0080134 |
regulation of response to stress
|
ALOX12, CYP19A1, DRD2, ESR1, F3, FABP4, HSP90AA1, HSP90AB1, IGF1R, MET, MMP2, PPARA, PPARG, SRC, XDH |
2.88028 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, ESR1, HSP90AB1, PPARG, SRC |
2.88028 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.88028 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.88028 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.88028 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.87245 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, KDR, MET, PPARA, PPARG |
2.87006 |
[BP] GO:2000278 |
regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, PPARG, SRC |
2.86525 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, MAOB |
2.83801 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG |
2.83801 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS |
2.83153 |
[BP] GO:0007187 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2 |
2.8302 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ALOX12, ALOX15, BCL2, CYP19A1, DRD1, DRD2, ESR1, ESR2, IGF1R, MET, MMP9, PPARA, PPARG, SRC, XDH |
2.82192 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.82192 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.82192 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD1, DRD2, FABP3, PPARA, PPARG, TRPV1 |
2.81831 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIM1, PPARA, PPARG |
2.77917 |
[BP] GO:0050878 |
regulation of body fluid levels
|
AKR1B1, ALOX12, CHRM1, CHRM3, DRD2, F3, MET, XDH |
2.73661 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP3A4, MAOB |
2.71981 |
[BP] GO:0070482 |
response to oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, PPARG, SRC |
2.71061 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ALOX15, AURKB, BCL2, CSNK2A1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, MMP9, NR3C1, PDE5A, PPARA, PPARG, SRC, XDH |
2.70553 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.6847 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, HSP90AA1, MAOB, PDE5A, SRC, XDH |
2.67593 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ALOX15, BCL2, CHRM5, DRD1, DRD2, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PPARA, SRC, XDH |
2.67172 |
[BP] GO:0044092 |
negative regulation of molecular function
|
AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PPARG, SRC |
2.67172 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, PPARG, SRC, TRPV1 |
2.65594 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AURKB, AXL, BCL2, DRD2, ESR1, IGF1R, KDR, MET, MMP1, MMP9, PPARG, SRC |
2.65594 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.64557 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ALOX15, BCL2, CHRM5, DRD1, DRD2, FABP3, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PPARA, SRC, XDH |
2.64367 |
[BP] GO:0065009 |
regulation of molecular function
|
AURKB, BCL2, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, HSP90AA1, HSP90AB1, IGF1R, MET, MMP9, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.61649 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PPARG, SRC |
2.59299 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PPARG, SRC, XDH |
2.59299 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, FDPS |
2.56333 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, AURKB, AXL, BCL2, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, HSP90AA1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PPARG, SRC, XDH |
2.56333 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ALOX15, AURKB, BCL2, CA9, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.56268 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F3, MET, SRC, XDH |
2.54515 |
[BP] GO:0007154 |
None
|
AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR2, PPARG, TRPV1 |
2.52802 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.52792 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, HSP90AA1, HSP90AB1, SRC |
2.51484 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, FDPS |
2.50318 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AURKB, DRD1, DRD2, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, NR3C1, PPARA, PPARG, SRC, TRPV1 |
2.49907 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
2.49581 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.47668 |
[BP] GO:0048545 |
response to steroid hormone
|
BCL2, CA2, FLT3, MAOB, NR3C1, SRC |
2.46848 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ALOX15, AURKB, BCL2, CA9, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.4663 |
[BP] GO:0015908 |
None
|
DRD2, FABP3, PPARA, PPARG |
2.45141 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.4313 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.4313 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, FLT3, PPARG |
2.42074 |
[BP] GO:1901361 |
None
|
CYP19A1, CYP1A1, CYP1A2, CYP2A6, CYP3A4, MAOB, PDE5A, XDH |
2.42016 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, HCAR2 |
2.40726 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.40174 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.40174 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, AXL, BCL2, CA2, CYP1B1, DRD2, F3, HSP90AB1, KDR, PDE5A, PIM1, PPARG, SRC |
2.38511 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.35094 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, HSP90AA1, KDR, SRC |
2.35094 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.34685 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PPARG, SRC, TRPV1, XDH |
2.34586 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, PPARG, SRC, XDH |
2.32666 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ALOX15, BCL2, DRD1, DRD2, FABP3, FLT3, HSP90AB1, KDR, MMP9, PDE5A, SRC, XDH |
2.32073 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ALOX15, BCL2, DRD1, DRD2, FABP3, FLT3, HSP90AB1, KDR, MMP9, PDE5A, SRC, XDH |
2.32073 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PPARG, SRC, TRPV1, XDH |
2.32072 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, PPARA, PPARG, SRC, TRPV1 |
2.3135 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, HSP90AB1, NR3C1, PPARG |
2.31327 |
[BP] GO:0034097 |
response to cytokine
|
ALOX15, AXL, BCL2, FABP4, FLT3, HSP90AB1, SRC, TRPV1 |
2.3022 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.28822 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, FLT3, PPARG |
2.28483 |
[BP] GO:0046320 |
None
|
FABP3, PPARA, PPARG |
2.2756 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, MAOB |
2.2756 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.2756 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.26798 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ALOX15, BCL2, DRD1, DRD2, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, PPARA, SRC, XDH |
2.25818 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
ESR1, ESR2, NR3C1, SRC |
2.25096 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, ALOX15, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F3, FLT3, HSP90AB1, IGF1R, KDR, MET, MMP9, PDE5A, PPARG, SRC, XDH |
2.23909 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.23909 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.23909 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.23909 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.23909 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.23909 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.23909 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.23909 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.23909 |
[BP] GO:0031960 |
response to corticosteroid
|
BCL2, FLT3, MAOB, NR3C1, SRC |
2.22206 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.21131 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, MAOB |
2.21131 |
[BP] GO:0002682 |
regulation of immune system process
|
ALOX15, AXL, BCL2, CA2, CYP19A1, DRD2, ESR1, HCAR2, HSP90AA1, HSP90AB1, MMP2, PDE5A, PPARG, SRC |
2.21094 |
[BP] GO:1901655 |
None
|
AKR1B1, NR3C1, PPARG, SRC |
2.21094 |
[BP] GO:0006810 |
None
|
ACHE, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, TRPV1, XDH |
2.19584 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.18348 |
[BP] GO:0044093 |
positive regulation of molecular function
|
AURKB, BCL2, DRD2, ESR1, ESR2, F3, FLT3, HSP90AA1, HSP90AB1, MET, MMP9, PDE5A, PPARG, SRC, XDH |
2.18314 |
[BP] GO:0001659 |
None
|
DRD1, DRD2, TRPV1 |
2.17893 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.17893 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.17893 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, NR3C1, PPARA, PPARG |
2.17344 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, AKR1B1, ALOX12, ALOX15, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.17258 |
[BP] GO:0001666 |
response to hypoxia
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.16719 |
[BP] GO:0051179 |
None
|
ACHE, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, ESR1, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, TRPV1, XDH |
2.15377 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, MAOB, XDH |
2.15338 |
[BP] GO:1901575 |
None
|
ACHE, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, HSP90AA1, MAOB, PDE5A, XDH |
2.14887 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.14846 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PPARG, SRC, TRPV1, XDH |
2.13882 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, IGF1R, MET, MMP9, SRC, XDH |
2.12556 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.11214 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AURKB, DRD1, DRD2, ESR1, ESR2, FABP3, HSP90AA1, HSP90AB1, IGF1R, MET, NR3C1, PPARA, PPARG, SRC, TRPV1 |
2.11214 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, TRPV1 |
2.11214 |
[BP] GO:0010887 |
None
|
PPARA, PPARG |
2.11214 |
[BP] GO:0010871 |
None
|
PPARA, PPARG |
2.11214 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.11214 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.11214 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.11214 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.11214 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.11214 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.11214 |
[BP] GO:0051234 |
None
|
ACHE, ALOX15, ALOX5, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, DRD1, DRD2, FABP3, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SRC, TRPV1, XDH |
2.11214 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ALOX15, BCL2, DRD1, DRD2, FABP4, FLT3, HSP90AB1, IGF1R, KDR, MMP9, PDE5A, SRC, XDH |
2.1018 |
[BP] GO:0016042 |
lipid catabolic process
|
CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.1018 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.10031 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
HSP90AA1, HSP90AB1, TRPV1, XDH |
2.08108 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, DRD1, IGF1R, MMP2, PPARG, SRC, TRPV1 |
2.06887 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, FABP4, MMP9 |
2.06739 |
[BP] GO:0043279 |
None
|
DRD2, HSP90AB1, PPARG, TRPV1 |
2.06739 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2 |
2.06534 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ALOX12, CYP19A1, DRD1, DRD2, PPARA, PPARG |
2.03403 |
[BP] GO:0051973 |
positive regulation of telomerase activity
|
AURKB, HSP90AA1, HSP90AB1 |
2.03087 |
[BP] GO:0009987 |
cellular process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.02454 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, FABP3, FABP4, MET |
2.01948 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, ESR1, MET, SRC |
2.0148 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ALOX15, BCL2, CSNK2A1, DRD2, ESR1, F3, FLT3, HSP90AB1, KDR, MMP9, PDE5A, PPARG, SRC, XDH |
2.00665 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5 |
2.00222 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, HSP90AA1, HSP90AB1, MET, SRC, TRPV1 |
3.96361 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX12, ALOX15, ALOX5, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, HCAR2, HSD11B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP2, PIM1, SRC, TRPV1 |
3.354 |
[CC] GO:0031253 |
None
|
CA4, CA9, DRD1, DRD2, HSP90AA1, HSP90AB1, SRC, TRPV1 |
3.354 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ALOX12, ALOX15, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, HCAR2, HSP90AA1, IGF1R, KDR, MET, MMP2, PIM1, SRC, TRPV1 |
3.03086 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.72548 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, BCL2, CA1, CA2, CA4, CA7, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, HSD11B1, HSD17B1, HSP90AA1, HSP90AB1, KDR, MAOB, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARG, SRC, TRPV1, XDH |
2.67172 |
[CC] GO:0044425 |
membrane part
|
ACHE, ALOX15, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, HCAR2, HSD11B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, SRC, TRPV1 |
2.61649 |
[CC] GO:0044459 |
plasma membrane part
|
ALOX15, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, SRC, TRPV1 |
2.54515 |
[CC] GO:0044463 |
None
|
AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, HSP90AA1, HSP90AB1, SRC, TRPV1 |
2.46305 |
[CC] GO:0120038 |
None
|
AKR1B1, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, HSP90AA1, HSP90AB1, SRC, TRPV1 |
2.46305 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.39432 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, IGF1R, KDR, MET, TRPV1 |
2.34663 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PPARG, XDH |
13.3221 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
13.1711 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.4934 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MET, PIM1, PPARA, PPARG, SRC, TRPV1 |
9.09957 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.66333 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
8.63333 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, F3, FDPS, FLT3, HSD11B1, HSD17B1, HSP90AA1, IGF1R, KDR, MAOB, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, SRC, XDH |
7.73842 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
7.32175 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, TRPV1, XDH |
7.19975 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.78139 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.65368 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, MAOB, XDH |
6.08071 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.98642 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.85116 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.85116 |
[MF] GO:0038023 |
signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, PPARG, TRPV1 |
5.7198 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.64796 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
5.40028 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NR3C1, PDE5A, PIM1, PPARA, PPARG, TRPV1, XDH |
5.0615 |
[MF] GO:0004872 |
receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, PPARG, TRPV1 |
4.95309 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.85857 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, PPARG, TRPV1 |
4.80927 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PPARA, PPARG |
4.78055 |
[MF] GO:0060089 |
molecular transducer activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, PPARG, TRPV1 |
4.77018 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, MAOB, SRC, XDH |
4.49882 |
[MF] GO:0004871 |
signal transducer activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, PPARG, TRPV1 |
4.38011 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.32726 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
4.14904 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2 |
3.90332 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2 |
3.86206 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, NR3C1, PPARA, PPARG |
3.85048 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.84108 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, HSP90AA1, IGF1R, KDR, MET, SRC |
3.79939 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.78431 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.77906 |
[MF] GO:0099600 |
transmembrane receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 |
3.5596 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARG, TRPV1 |
3.5596 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.54719 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, BCL2, CSNK2A1, DRD2, ESR1, ESR2, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, MMP9, PPARG, TRPV1, XDH |
3.52241 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.354 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.24674 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, HSD17B1, IGF1R, NR3C1 |
3.21866 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, HSD17B1, NR3C1 |
3.19994 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.03086 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
3.03086 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.03086 |
[MF] GO:0043168 |
anion binding
|
ALOX15, AURKB, AXL, CSNK2A1, F3, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PPARG, SRC, TRPV1, XDH |
2.88921 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, PPARG |
2.88172 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, PPARG |
2.88172 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, MAOB, XDH |
2.82192 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.79925 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.64557 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.64557 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.64557 |
[MF] GO:0036094 |
small molecule binding
|
AURKB, AXL, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, PDE5A, PIM1, PPARG, SRC, TRPV1, XDH |
2.56129 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.40174 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.40174 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.40174 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.34685 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2 |
2.33523 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.3135 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.3135 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.3135 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.25224 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.23909 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.23909 |
[MF] GO:0004629 |
None
|
CHRM1, CHRM3, CHRM5 |
2.21131 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.14846 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, CSNK2A1, FLT3, HSP90AA1, HSP90AB1, IGF1R, KDR, MMP9, PIM1, PPARA, SRC |
2.14846 |
[MF] GO:0050543 |
None
|
FABP3, PPARG |
2.11214 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.11214 |
[MF] GO:0035258 |
None
|
ESR1, FLT3, PPARG, SRC |
2.11214 |
[MF] GO:0097159 |
organic cyclic compound binding
|
AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FDPS, FLT3, HSD17B1, HSP90AA1, HSP90AB1, IGF1R, KDR, MAOB, MET, NR3C1, PDE5A, PIM1, PPARA, PPARG, SRC, TRPV1, XDH |
2.1018 |
[MF] GO:0008081 |
None
|
CHRM1, CHRM3, CHRM5, PDE5A |
2.06739 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, FLT3, HSP90AA1, IGF1R, KDR, MET, PIM1, SRC |
2.01948 |